FMC DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds FMC (NYSE: FMC) Investors of Securities Class Action Lawsuit Deadline on January 19, 2027
FMC DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds FMC (NYSE: FMC) Investors of Securities Class Action Lawsuit Deadline on January 19, 2027
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in FMC between February 4, 2026 and October 14, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) and reminds investors of the January 19, 2027 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of FMC's distributor-inventory problem, including the extent to which elevated-priced inventory held by distributors was difficult to sell thereby impairing replenishment orders across FMC's portfolio and threatening the Company's ability to generate new sales, revenue, EBITDA and cash flow.
On October 14, 2026, FMC announced preliminary third quarter 2026 results materially below expectations and sharply reduced its revenue and adjusted EBITDA for the quarter. On this news, FMC's stock price fell $2.47, or approximately 31%, to close at $5.62 per share on October 15, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding FMC’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the FMC class action, go to www.faruqilaw.com/FMC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the FMC Securities Class Action Lawsuit:
What is the FMC securities fraud lawsuit about?
The lawsuit alleges that FMC Corporation and certain of its officers made materially false and misleading statements to investors during the Class Period while allegedly concealing the true severity of FMC's distributor-inventory problem. Specifically, the complaint alleges that defendants knew or recklessly disregarded that elevated-priced inventory held by distributors was difficult to sell, which allegedly impaired replenishment orders across FMC's portfolio. The lawsuit further alleges that this undisclosed condition threatened FMC's ability to generate new sales, revenue, EBITDA, and cash flow. Defendants allegedly provided overwhelmingly positive statements to investors that did not accurately reflect these material adverse facts.
Who may be eligible to participate in the lawsuit?
Investors who purchased or otherwise acquired FMC Corporation (NYSE: FMC) securities on the New York Stock Exchange between February 4, 2026 and October 14, 2026, inclusive, may be eligible to participate in this lawsuit. Eligibility to participate in any potential recovery is not limited to those who seek appointment as lead plaintiff; any class member who suffered losses during the Class Period may be entitled to share in a recovery. Investors who believe they may qualify are encouraged to review the complaint and consult with counsel to understand their rights and options.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff is a court-appointed representative who acts on behalf of all class members in directing the litigation, including making key strategic decisions in coordination with counsel. Any investor who purchased FMC securities during the Class Period and suffered a loss may move the court for appointment as lead plaintiff, and the deadline to file such a motion is January 19, 2027. Importantly, investors are not required to serve as lead plaintiff in order to be eligible to share in any recovery that may result from the lawsuit. Class members who do not seek lead plaintiff status will still have the opportunity to participate in any settlement or judgment obtained on behalf of the class.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased FMC securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Contacts
Faruqi & Faruqi, LLP
Josh Wilson
877-247-4292 or 212-983-9330 (Ext. 1310)

